Peter S. Park founded Park West Asset Management in November 2002. As the firm’s Chief Investment Officer, Mr. Park oversees operations. The company was founded a year after the 9/11 terrorist attacks in the United States and is situated in Larkspur, California. Park West Asset Management invests in firms that have strong fundamentals and can grow in the future. To take advantage of changing market conditions, Peter S. Park’s fund may diversify its portfolio from time to time.
Here is Insider Monkey’s list of the 10 healthcare stocks to buy according to Peter S. Park’s Park West Asset Management. Viking Therapeutics, Inc. is a biopharmaceutical company that develops therapies for metabolic and endocrine illnesses. According to Peter S. Park’s Park West Asset Management, the company was founded in 2012 and is ranked tenth among the top ten healthcare companies to buy. Angion Biomedica Corp. is a biopharmaceutical company specializing in small molecule therapy development, marketing, and discovery. With 1.04 million shares worth $13.50 million, Mark Lampert’s Biotechnology Value Fund / BVF Inc is the largest stakeholder. The Beauty Health Company is a cosmetics and health company that focuses on product development. Peter S. Park’s hedge fund purchased around 1.03 million shares for $17.27 million, making it a fresh addition to his portfolio. According to Peter S. Park’s Park West Asset Management, PLx Pharma Inc. is ranked seventh among the top ten healthcare stocks to purchase. The drug delivery platform developed by the business has been clinically verified and is protected by a patent. Through its subsidiary, Evolent Health LLC, Evolent Health, Inc. provides health care delivery and payment systems in the United States. According to Peter S. Park’s Park West Asset Management, it is placed sixth among the top ten healthcare companies to purchase. For more details, click 10 Healthcare Stocks To Buy According To Peter S. Park’s Park West Asset Management.